144 related articles for article (PubMed ID: 2881449)
1. Transmitter receptor alterations in Parkinson's disease.
Calne DB; Stoessl AJ
Adv Neurol; 1987; 45():45-9. PubMed ID: 2881449
[No Abstract] [Full Text] [Related]
2. Autoradiographic distributions of neurotransmitter receptors in the human brains of Parkinson's disease and primate models of MPTP-induced parkinsonism.
Kito S; Miyoshi R; Mizuno K; Nitta K; Matsubayashi H; Yamamura Y; Tahara E
Adv Neurol; 1987; 45():159-65. PubMed ID: 2881441
[No Abstract] [Full Text] [Related]
3. Neurotransmitter receptor mapping by autoradiography and other methods.
Kuhar MJ; De Souza EB; Unnerstall JR
Annu Rev Neurosci; 1986; 9():27-59. PubMed ID: 2423006
[No Abstract] [Full Text] [Related]
4. [Problems and future perspectives in the treatment of Parkinson's disease].
Hens L; Hellemans J
Tijdschr Gerontol Geriatr; 1982 Aug; 13(4):147-54. PubMed ID: 6127822
[TBL] [Abstract][Full Text] [Related]
5. Neurotransmitter receptor alterations in Parkinson's disease.
Reisine TD; Fields JZ; Yamamura HI
Life Sci; 1977 Aug; 21(3):335-43. PubMed ID: 197361
[No Abstract] [Full Text] [Related]
6. Brain neurotransmitters and neuropeptides in Parkinson's disease.
Rinne UK; Rinne JO; Rinne JK; Laakso K; Lönnberg P
Acta Physiol Pharmacol Latinoam; 1984; 34(3):287-99. PubMed ID: 6099688
[TBL] [Abstract][Full Text] [Related]
7. Nondopaminergic neurons in Parkinson's disease.
Hirsch EC; Orieux G; Muriel MP; Francois C; Feger J
Adv Neurol; 2003; 91():29-37. PubMed ID: 12449099
[No Abstract] [Full Text] [Related]
8. Drug-induced alterations in neurotransmitter receptor binding and function.
Enna SJ; Ferkany JW; Strong R
Adv Biochem Psychopharmacol; 1980; 21():253-63. PubMed ID: 6246740
[No Abstract] [Full Text] [Related]
9. Biochemical pathophysiology of Parkinson's disease.
Hornykiewicz O; Kish SJ
Adv Neurol; 1987; 45():19-34. PubMed ID: 2881444
[No Abstract] [Full Text] [Related]
10. Receptor imaging by positron emission tomography and single-photon emission computed tomography.
Frost JJ
Invest Radiol; 1992 Dec; 27 Suppl 2():S54-8. PubMed ID: 1334949
[TBL] [Abstract][Full Text] [Related]
11. A Markov process based model of the neurotransmitter-receptor binding process in the brain.
Elkarmi AZ; Karmi MZ; Alkarmi ZM
Drug Des Deliv; 1988 Jul; 3(1):69-76. PubMed ID: 2908226
[TBL] [Abstract][Full Text] [Related]
12. Electroconvulsive shock and neurotransmitter receptors: implications for mechanism of action and adverse effects of electroconvulsive therapy.
Lerer B
Biol Psychiatry; 1984 Mar; 19(3):361-83. PubMed ID: 6144329
[TBL] [Abstract][Full Text] [Related]
13. [Regulatory effects of the presynaptic receptors on transmitter release (author's transl)].
Yang K
Sheng Li Ke Xue Jin Zhan; 1982 Jan; 13(1):43-7. PubMed ID: 6125032
[No Abstract] [Full Text] [Related]
14. Absolute quantification by positron emission tomography of the endogenous ligand.
Delforge J; Bottlaender M; Pappata S; Loc'h C; Syrota A
J Cereb Blood Flow Metab; 2001 May; 21(5):613-30. PubMed ID: 11333372
[TBL] [Abstract][Full Text] [Related]
15. Brain enkephalin receptors in Parkinson's disease.
Rinne UK; Rinne JK; Rinne JO; Laakso K; Tenovuo O; Lönnberg P; Koskinen V
J Neural Transm Suppl; 1983; 19():163-71. PubMed ID: 6321647
[TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography studies of brain receptors.
Mazière B; Mazière M
Fundam Clin Pharmacol; 1991; 5(1):61-91. PubMed ID: 1676695
[TBL] [Abstract][Full Text] [Related]
17. Environmental enrichment and neurotransmitter receptors.
Por SB; Bennett EL; Bondy SC
Behav Neural Biol; 1982 Feb; 34(2):132-40. PubMed ID: 6123308
[No Abstract] [Full Text] [Related]
18. Parkinson's disease: nigral receptor changes support peptidergic role in nigrostriatal modulation.
Uhl GR; Hackney GO; Torchia M; Stranov V; Tourtellotte WW; Whitehouse PJ; Tran V; Strittmatter S
Ann Neurol; 1986 Aug; 20(2):194-203. PubMed ID: 3019228
[TBL] [Abstract][Full Text] [Related]
19. Positron emission tomography for quantitative in vivo studies of neurotransmitter kinetics: a critical evaluation.
Greitz T
Adv Biochem Psychopharmacol; 1984; 39():69-78. PubMed ID: 6147069
[No Abstract] [Full Text] [Related]
20. Therapeutic use of release-modifying drugs.
Langer SZ
Handb Exp Pharmacol; 2008; (184):561-73. PubMed ID: 18064425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
